| 1 |
Xie B, Zhu Y, Shen Y, Xu W, Song X. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection. Expert Opin Ther Targets 2023. [PMID: 36947026 DOI: 10.1080/14728222.2023.2193329] [Reference Citation Analysis]
|
| 2 |
Diotallevi F, Gioacchini H, De Simoni E, Marani A, Candelora M, Paolinelli M, Molinelli E, Offidani A, Simonetti O. Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art. Int J Mol Sci 2023;24. [PMID: 36902341 DOI: 10.3390/ijms24054910] [Reference Citation Analysis]
|
| 3 |
Zhang M, Xia T, Lin F, Yu J, Yang Y, Lei W, Zhang T. Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm. Transpl Immunol 2023;76:101766. [PMID: 36464219 DOI: 10.1016/j.trim.2022.101766] [Reference Citation Analysis]
|
| 4 |
Zhou F, Lu X, He F, Wu T, Aisa HA, Maiwulanjiang M. Effects of traditional artiri La Li formulation on experimental models of vitiligo and mechanisms of melanogenesis. Journal of Ethnopharmacology 2023;302:115884. [DOI: 10.1016/j.jep.2022.115884] [Reference Citation Analysis]
|
| 5 |
Borgia F, Li Pomi F, Vaccaro M, Alessandrello C, Papa V, Gangemi S. Oxidative Stress and Phototherapy in Atopic Dermatitis: Mechanisms, Role, and Future Perspectives. Biomolecules 2022;12. [PMID: 36551332 DOI: 10.3390/biom12121904] [Reference Citation Analysis]
|
| 6 |
Buglak AA, Kapitonova MA, Vechtomova YL, Telegina TA. Insights into Molecular Structure of Pterins Suitable for Biomedical Applications. Int J Mol Sci 2022;23. [PMID: 36499560 DOI: 10.3390/ijms232315222] [Reference Citation Analysis]
|
| 7 |
Wang J, Pan Y, Wei G, Mao H, Liu R, He Y. Damage-associated molecular patterns in vitiligo: igniter fuse from oxidative stress to melanocyte loss. Redox Rep 2022;27:193-9. [PMID: 36154894 DOI: 10.1080/13510002.2022.2123864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Maghfour J, Hamzavi IH, Mohammad TF. An updated review on systemic and targeted therapies for vitiligo. Dermatological Reviews 2022. [DOI: 10.1002/der2.166] [Reference Citation Analysis]
|
| 9 |
Bellei B, Papaccio F, Picardo M. Regenerative Medicine-Based Treatment for Vitiligo: An Overview. Biomedicines 2022;10:2744. [DOI: 10.3390/biomedicines10112744] [Reference Citation Analysis]
|
| 10 |
Yu X, Cui Y, Zhu X, Xu H, Li L, Gao G. MicroRNAs: Emerging players in the pathogenesis of vitiligo. Front Cell Dev Biol 2022;10:964982. [DOI: 10.3389/fcell.2022.964982] [Reference Citation Analysis]
|
| 11 |
Dutta T, Mitra S, Saha A, Ganguly K, Pyne T, Sengupta M. A comprehensive meta-analysis and prioritization study to identify vitiligo associated coding and non-coding SNV candidates using web-based bioinformatics tools. Sci Rep 2022;12:14543. [PMID: 36008553 DOI: 10.1038/s41598-022-18766-9] [Reference Citation Analysis]
|
| 12 |
Hlača N, Žagar T, Kaštelan M, Brajac I, Prpić-massari L. Current Concepts of Vitiligo Immunopathogenesis. Biomedicines 2022;10:1639. [DOI: 10.3390/biomedicines10071639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Al-harthi F, Huraib GB, Mustafa M, Al-qubaisy Y, Al-nomair N, Abdurrahman N, Al-asmari A. Inducible Nitric Oxide Synthase iNOS-954-G>C and Ex16+14-C>T Gene Polymorphisms and Susceptibility to Vitiligo in the Saudi Population. PGPM 2022;Volume 15:603-612. [DOI: 10.2147/pgpm.s344415] [Reference Citation Analysis]
|
| 14 |
Fus-kujawa A, Sieroń Ł, Dobrzyńska E, Chajec Ł, Mendrek B, Jarosz N, Głowacki Ł, Dubaj K, Dubaj W, Kowalczuk A, Bajdak-rusinek K. Star Polymers as Non-Viral Carriers for Apoptosis Induction. Biomolecules 2022;12:608. [DOI: 10.3390/biom12050608] [Reference Citation Analysis]
|
